What is the recommended pediatric dose of domperidone (mg per kilogram) for children older than 12 months, including maximum single and daily doses and relevant safety contraindications?

Domperidone Dosing in Pediatric Patients

For children older than 12 months, domperidone is dosed at 0.2 mg/kg three times daily (approximately 0.6 mg/kg/day) or alternatively 2 mg/kg/day divided into four doses, with a maximum single dose not exceeding 10 mg and a maximum daily dose of 30 mg. 1

Age-Specific Dosing Regimens

Children 1 Month to 12.7 Years

• Standard regimen: 2 mg/kg/day divided into four daily doses 1
• This dosing showed 100% improvement in cough symptoms in an uncontrolled 2006 study, though the evidence quality is limited 1

Infants (Alternative Regimen)

• Higher-dose regimen: 0.2 mg/kg three times daily 1
• This regimen demonstrated 64.5% improvement in cough symptoms in infants, though again from uncontrolled data 1

Maximum Dose Limitations

Critical safety ceiling: The maximum daily dose should not exceed 30 mg regardless of weight-based calculations 2

• Individual doses should be capped at 10 mg per administration 2
• Doses above 30 mg daily significantly increase the risk of fatal cardiac arrhythmias 2

Cardiac Safety Monitoring

Domperidone carries a risk of QT interval prolongation and potentially fatal ventricular arrhythmias, particularly in vulnerable populations. 3, 4

Baseline and Ongoing ECG Monitoring

• Obtain a baseline electrocardiogram before initiating domperidone 3
• Perform follow-up ECGs at 3,7, and 14 days after starting treatment 5
• A corrected QT (QTc) interval exceeding 450 ms warrants immediate reassessment 5

High-Risk Populations Requiring Extra Vigilance

• Premature infants: Two of 40 premature infants developed QTc prolongation >450 ms on 1 mg/kg/day, though this resolved spontaneously 4, 5
• Neonates: Nine of 31 neonates showed QTc prolongation >30 ms on an average dose of 1.3 mg/kg/day 4
• Infants with electrolyte abnormalities: Hypokalemia, hypomagnesemia, or hypocalcemia increase arrhythmia risk 3

Contraindications and Drug Interactions

Avoid domperidone in patients taking medications that prolong the QT interval, as this dramatically increases the risk of sudden cardiac arrest. 2

• More than 120 drugs can prolong the QT interval 2
• Concurrent use of these medications with domperidone should be strictly avoided 2
• Review all medications for potential QT-prolonging effects before prescribing domperidone 2

Evidence Quality and Off-Label Use

The evidence supporting domperidone efficacy in pediatric gastrointestinal disorders is limited and of low quality. 1, 6

• Current authorization restricts use to relief of nausea and vomiting in children older than 12 years for short periods 6
• Pediatric gastroenterologists commonly use domperidone off-label for gastroesophageal reflux disease, dyspepsia, and gastroparesis 6
• The 2006 study supporting the dosing regimens was uncontrolled and lacks robust methodology 1
• Controversial data exist regarding efficacy in pediatric gastrointestinal motility disorders 6

Clinical Decision Algorithm

1. Verify age eligibility: Child must be >12 months for standard use 1
2. Calculate weight-based dose: 0.2 mg/kg TID or 2 mg/kg/day divided QID 1
3. Apply maximum dose caps: Single dose ≤10 mg, daily dose ≤30 mg 2
4. Screen for cardiac risk factors: Electrolyte abnormalities, congenital heart disease, family history of sudden cardiac death 3
5. Review medication list: Identify and eliminate QT-prolonging drugs 2
6. Obtain baseline ECG: Measure QTc interval before first dose 3, 5
7. Monitor serially: Repeat ECG at days 3,7, and 14 5
8. Discontinue if QTc >450 ms: Stop domperidone and reassess cardiac status 5

Common Pitfalls to Avoid

• Exceeding 30 mg daily: This threshold significantly increases fatal arrhythmia risk 2
• Skipping ECG monitoring: Pathological QTc intervals occurred in small numbers of infants across multiple studies 3, 4
• Ignoring drug interactions: Simultaneous use of QT-prolonging medications is a critical oversight 2
• Assuming safety in premature infants: This population showed QTc prolongation even at modest doses of 1 mg/kg/day 4, 5
• Relying on symptom monitoring alone: QTc prolongation can be asymptomatic before sudden cardiac events 3